Yuri Maricich, MD, MBA; | Chief Medical Officer
CAMP4 Therapeutics

Yuri Maricich, M.D., M.B.A., serves as Chief Medical Officer at CAMP4. Dr. Maricich is a “full-stack”, licensed physician-scientist, clinical/therapeutic developer, investor, and strategist. His background includes clinical practice as an internal medicine physician and leading teams and developing therapeutics at companies which include Xdynia (acquired Cavion), Cavion (acq Jazz Pharmaceuticals), Corixa (acq GlaxoSmithKline), Pear Therapeutics (public, 3 FDA authorized products including, Somryst – Prix Galien best product).  He is a Venture Partner & Advisor, Angelini Ventures. Dr. Maricich has experience developing therapeutics / products across the entire product life cycle from discovery, pre-clinical, IND, clinical development, FDA approval/authorization, and post-market studies.  He has worked across biotech (therapeutics – small molecules, RNA, gene therapies – AI/ML, drug discovery, multiple disease areas & development stages), , medical / connected health devices, digital health, and healthcare delivery. Dr. Maricich completed his education and training at Harvard University, University of Washington, University of Notre Dame, and the University of Virginia.